Literature DB >> 22158048

The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4.

S J Lubbe1, A M Pittman, B Olver, A Lloyd, J Vijayakrishnan, S Naranjo, S Dobbins, P Broderick, J L Gómez-Skarmeta, R S Houlston.   

Abstract

Common genetic variation at human 14q22.2 tagged by rs4444235 is significantly associated with colorectal cancer (CRC) risk. Re-sequencing was used to comprehensively annotate the 17kb region of strong linkage disequilibrium encompassing rs4444235. Through bioinformatic analyses using H3K4Me1, H3K4Me3, and DNase-I hypersensitivity chromatin signatures and evolutionary conservation we identified seven candidate disease-causing single-nucleotide polymorphisms mapping to six regions within the 17-kb region predicted to have regulatory potential. Reporter gene studies of these regions demonstrated that the element to which rs4444235 maps acts as an allele-specific transcriptional enhancer. Allele-specific expression studies in CRC cell lines heterozygous for rs4444235 showed significantly increased expression of bone morphogenetic protein-4 (BMP4) associated with the risk allele (P<0.001). These data provide evidence for a functional basis for the non-coding risk variant rs4444235 at 14q22.2 and emphasizes the importance of genetic variation in the BMP pathway genes as determinants of CRC risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158048     DOI: 10.1038/onc.2011.564

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Association of colorectal cancer susceptibility variants with esophageal cancer in a Chinese population.

Authors:  Ting-Ting Geng; Xiao-Jie Xun; Sen Li; Tian Feng; Li-Ping Wang; Tian-Bo Jin; Peng Hou
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

2.  A subset of genetic susceptibility variants for colorectal cancer also has prognostic value.

Authors:  S Noci; M Dugo; F Bertola; F Melotti; A Vannelli; T A Dragani; A Galvan
Journal:  Pharmacogenomics J       Date:  2015-05-12       Impact factor: 3.550

Review 3.  Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk.

Authors:  Amal Ahmed Abd El-Fattah; Nermin Abdel Hamid Sadik; Olfat Gamil Shaker; Amal Mohamed Kamal
Journal:  Mediators Inflamm       Date:  2018-10-25       Impact factor: 4.711

Review 4.  Genetic architecture of colorectal cancer.

Authors:  Ulrike Peters; Stephanie Bien; Niha Zubair
Journal:  Gut       Date:  2015-07-17       Impact factor: 23.059

Review 5.  Disruption of long-range gene regulation in human genetic disease: a kaleidoscope of general principles, diverse mechanisms and unique phenotypic consequences.

Authors:  Shipra Bhatia; Dirk A Kleinjan
Journal:  Hum Genet       Date:  2014-02-05       Impact factor: 4.132

6.  Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells.

Authors:  Jelena Mihajlović; Laura A M Diehl; Andreas Hochhaus; Joachim H Clement
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-17       Impact factor: 4.553

7.  A 190 base pair, TGF-β responsive tooth and fin enhancer is required for stickleback Bmp6 expression.

Authors:  Priscilla A Erickson; Phillip A Cleves; Nicholas A Ellis; Kevin T Schwalbach; James C Hart; Craig T Miller
Journal:  Dev Biol       Date:  2015-02-27       Impact factor: 3.582

8.  Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease.

Authors:  Scott Smemo; Luciene C Campos; Ivan P Moskowitz; José E Krieger; Alexandre C Pereira; Marcelo A Nobrega
Journal:  Hum Mol Genet       Date:  2012-04-27       Impact factor: 6.150

Review 9.  Transcriptional regulation and its misregulation in disease.

Authors:  Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

10.  Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.

Authors:  Qiangqiang Zheng; Shihui Min; Qinghua Zhou
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.